Update All
   ✏️  Posts: 16,730
 ✏️  Posts: 16,730

 1. COVID19 Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults
2023-04-01 13:34:20 EST Source
 2. COVID19 Your outpatient has COVID-19: what are their treatment options in the current SARS-CoV-2 variant climate?
2023-04-01 10:17:49 EST Source
 3. COVID19 Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients
2023-04-01 07:24:32 EST Source
 4. COVID19 COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample
2023-04-01 06:20:55 EST Source
 5. COVID19 A National Survey of Children, Adults, and the Elderly in the Fourth Wave of the COVID-19 Pandemic to Compare Acute and Post-COVID-19 Conditions in Saudi Arabia
2023-04-01 05:30:43 EST Source
 6. COVID19 Human disturbance increases coronavirus prevalence in bats
2023-03-31 16:26:23 EST Source
 7. COVID19 Pseudomonas aeruginosa Bloodstream Infections in SARS-CoV-2 Infected Patients: A Systematic Review
2023-03-31 08:57:01 EST Source
 8. COVID19 Assessing the Outcomes of Patients with Severe SARS-CoV-2 Infection after Therapeutic Plasma Exchange by Number of TPE Sessions
2023-03-31 06:42:56 EST Source
 9. COVID19 Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study
2023-03-31 05:30:02 EST Source
 10. COVID19 Rapid flow cytometric analysis of fibrin amyloid microclots in Long COVID
2023-03-30 11:31:55 EST Source
 11. COVID19 SARS-CoV-2 Infection and Clinical Signs in Cats and Dogs from Confirmed Positive Households in Germany
2023-03-30 08:33:46 EST Source
 12. COVID19 Mitigation behavior prior to COVID-19 vaccination availability is associated with COVID-19 infection and time to vaccination
2023-03-30 07:30:39 EST Source
 13. COVID19 Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID
2023-03-30 06:59:53 EST Source
 14. COVID19 Epidemic efficacy of Covid-19 vaccination against Omicron: An innovative approach using enhanced residual recurrent neural network
2023-03-30 06:35:00 EST Source
 15. COVID19 Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder
2023-03-30 05:30:15 EST Source
 16. COVID19 mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5 - Nature Communications
2023-03-29 22:30:21 EST Source
 17. COVID19 A multicentre study reveals dysbiosis in the microbial co-infection and antimicrobial resistance gene profile in the nasopharynx of COVID-19 patients
2023-03-29 08:49:21 EST Source
 18. COVID19 Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study
2023-03-29 07:28:26 EST Source
 19. COVID19 Extraction-free clinical detection of SARS-CoV-2 virus from saline gargle samples using Hamilton STARlet liquid handler
2023-03-29 06:49:03 EST Source
 20. COVID19 An Oral Galectin Inhibitor in COVID-19—A Phase II Randomized Controlled Trial
2023-03-28 23:26:50 EST Source
 21. COVID19 WHO revises COVID-19 vaccine recommendations for Omicron-era
2023-03-28 19:56:56 EST Source
 22. COVID19 SARS-CoV-2 ORF3c suppresses immune activation by inhibiting innate sensing
2023-03-28 19:16:01 EST Source
 23. COVID19 Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study
2023-03-28 10:15:56 EST Source
 24. COVID19 Spatial–temporal distribution of incidence, mortality, and case-fatality ratios of coronavirus disease 2019 and its social determinants in Brazilian municipalities
2023-03-28 07:57:07 EST Source
 25. COVID19 Stress native T1 and native T2 mapping compared to myocardial perfusion reserve in long-term follow-up of severe Covid-19
2023-03-28 06:59:26 EST Source
 26. COVID19 Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study
2023-03-28 05:47:31 EST Source
 27. COVID19 Great deal Brand new cases of 440 3M Aura N95 1870+ $300/Case when buying Bulk
2023-03-27 21:42:22 EST Source
 28. COVID19 IgG4 Antibodies Induced by mRNA Vaccines Generate Immune Tolerance to SARS-CoV-2’spike Protein by Suppressing the Immune System
2023-03-27 13:37:28 EST Source
 29. COVID19 Walgreens COVID Index
2023-03-27 11:41:02 EST Source
 30. COVID19 Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
2023-03-27 09:40:57 EST Source
 31. COVID19 Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana
2023-03-27 08:54:17 EST Source
 32. COVID19 Weekly Scientific Discussion Thread - March 27, 2023
2023-03-27 08:00:32 EST Source
 33. COVID19 Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort
2023-03-27 07:47:35 EST Source
 34. COVID19 Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings
2023-03-27 06:44:46 EST Source
 35. COVID19 Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19
2023-03-26 18:11:20 EST Source
 36. COVID19 Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
2023-03-26 15:22:52 EST Source
 37. COVID19 Impact of persistent D-dimer elevation following recovery from COVID-19
2023-03-26 15:09:33 EST Source
 38. COVID19 COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study
2023-03-26 08:37:38 EST Source
 39. COVID19 Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates
2023-03-26 07:44:23 EST Source
 40. COVID19 Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting
2023-03-26 06:43:55 EST Source
 41. COVID19 Evaluation of SARS-CoV-2 ORF7a Deletions from COVID-19-Positive Individuals and Its Impact on Virus Spread in Cell Culture
2023-03-26 05:11:50 EST Source
 42. COVID19 Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants
2023-03-25 14:33:54 EST Source
 43. COVID19 Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France
2023-03-25 08:47:55 EST Source
 44. COVID19 Cardiopulmonary Exercise Testing in Children and Young Adolescents after a Multisystem Inflammatory Syndrome: Physical Deconditioning or Residual Pathology?
2023-03-25 07:35:48 EST Source
 45. COVID19 Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study
2023-03-25 06:50:29 EST Source
 46. COVID19 Computational prediction of interactions between Paxlovid and prescription drugs
2023-03-25 05:44:10 EST Source
 47. COVID19 Unraveling the Underlying Molecular Mechanism of 'Silent Hypoxia' in COVID-19 Patients Suggests a Central Role for Angiotensin II Modulation of the AT1R-Hypoxia-Inducible Factor Signaling Pathway
2023-03-24 09:28:34 EST Source
 48. COVID19 A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452
2023-03-24 08:28:10 EST Source
 49. COVID19 Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
2023-03-24 06:32:35 EST Source
 50. COVID19 A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
2023-03-24 05:39:25 EST Source
 51. COVID19 Former CDC director testifies that COVID-19 most likely originated from Wuhan lab </span>Smith, Burgess introduce legislation to allow US citizens the right to sue Chinese Communist Party for its COVID-19 misrepresentation campaign #Covid-19 #ccpvirus
2023-03-24 02:58:32 EST Source
 52. COVID19 Former CDC director testifies that COVID-19 most likely originated from Wuhan lab Smith, Burgess introduce legislation to allow US citizens the right to sue Chinese Communist Party for its COVID-19 misrepresentation campaign | U.S. Representative
2023-03-24 02:54:59 EST Source
 53. COVID19 Nirmatrelvir and the Risk of Post–COVID-19 Condition
2023-03-24 01:09:15 EST Source
 54. COVID19 Risk Factors for Post−COVID-19 Condition
2023-03-24 01:04:46 EST Source
 55. COVID19 Prion-like Domains in Eukaryotic Viruses
2023-03-23 09:44:20 EST Source
 56. COVID19 Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study
2023-03-23 08:51:32 EST Source
 57. COVID19 Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial
2023-03-23 07:57:30 EST Source
 58. COVID19 SARS-CoV-2 wastewater-based epidemiology in an enclosed compound: A 2.5-year survey to identify factors contributing to local community dissemination
2023-03-23 06:47:52 EST Source
 59. COVID19 Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system
2023-03-23 05:19:08 EST Source
 60. COVID19 Long-term wastewater-based surveillance and impacts of the COVID-19 pandemic on drug use trends in a U.S. Northeast rural town
2023-03-22 09:18:54 EST Source
 61. COVID19 Deaths from undetected COVID-19 infections as a fraction of COVID-19 deaths can be used for early detection of an upcoming epidemic wave
2023-03-22 08:08:37 EST Source
 62. COVID19 Stabilization of SARS-CoV-2 RNA in wastewater via rapid RNA extraction
2023-03-22 06:52:35 EST Source
 63. COVID19 Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
2023-03-22 05:39:04 EST Source
 64. COVID19 Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study
2023-03-21 14:47:04 EST Source
 65. COVID19 Safety and Effectiveness of SA58 Nasal Spray against SARS-CoV-2 family transmission: an exploratory single-arm trial
2023-03-21 14:25:06 EST Source
 66. COVID19 A cross-sectional analysis of the predictors of COVID-19 vaccine uptake and vaccine hesitancy in Iraq
2023-03-21 08:11:27 EST Source
 67. COVID19 Persistence of SARS-CoV-2 in saliva: Implications for late-stage diagnosis and infectious duration
2023-03-21 07:26:10 EST Source
 68. COVID19 Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
2023-03-21 06:02:41 EST Source
 69. COVID19 Genetic evidence of susceptible wildlife in SARS-CoV-2 positive samples at the Huanan Wholesale Seafood Market, Wuhan: Analysis and interpretation of data released by the Chinese Center for Disease Control
2023-03-20 19:43:53 EST Source
 70. COVID19 Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age
2023-03-20 10:34:21 EST Source
 71. COVID19 COVID-19 and non-Hodgkin’s lymphoma: A common susceptibility pattern?
2023-03-20 08:47:34 EST Source
 72. COVID19 Weekly Scientific Discussion Thread - March 20, 2023
2023-03-20 08:00:31 EST Source
 73. COVID19 Impact of the COVID-19 pandemic on emergent stroke care in Beijing, China
2023-03-20 07:37:08 EST Source
 74. COVID19 The effect of SARS-CoV-2 variant on respiratory features and mortality
2023-03-20 06:53:24 EST Source
 75. COVID19 When should healthcare workers with COVID-19 return to work? An analysis of follow-up antigen test results after a positive COVID test
2023-03-20 05:30:35 EST Source
 76. COVID19 Effectiveness of fourth dose of COVID-19 mRNA vaccine in elderly population during Omicron BA.2 and BA.5 circulation: nationwide cohort study in Korea (K-COVE)
2023-03-19 09:53:21 EST Source
 77. COVID19 Community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection
2023-03-19 08:27:46 EST Source
 78. COVID19 Risk of Coronavirus Disease 2019–Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients
2023-03-19 06:49:03 EST Source
 79. COVID19 Role of IP-10 to predict clinical progression and response to IL-6 blockade with Sarilumab in early COVID-19 pneumonia. A subanalysis of the SARICOR clinical trial
2023-03-19 05:47:45 EST Source
 80. COVID19 Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine
2023-03-18 21:36:05 EST Source
 81. COVID19 Severity and geographical disparities of post-COVID-19 symptoms among the Vietnamese general population: a national evaluation
2023-03-18 09:23:54 EST Source
 82. COVID19 A neural signature of exposure to masked faces after 18 months of COVID-19
2023-03-18 07:16:02 EST Source
 83. COVID19 Are covered faces eye-catching for us? The impact of masks on attentional processing of self and other faces during the COVID-19 pandemic
2023-03-18 07:12:31 EST Source
 84. COVID19 Cognitive impairment in people with previous COVID-19 infection: A scoping review
2023-03-18 05:43:51 EST Source
 85. COVID19 Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections
2023-03-17 09:27:01 EST Source
 86. COVID19 Immunity of heterologous and homologous boosted or convalescent individuals against Omicron BA.1, BA.2 and BA.4/5 variants
2023-03-17 08:18:08 EST Source
 87. COVID19 Total and subgenomic RNA viral load in patients infected with SARS-CoV-2 Alpha, Delta, and Omicron variants
2023-03-17 07:00:57 EST Source
 88. COVID19 Appropriate outcome settings for the effectiveness of oral zinc treatment for Coronavirus Disease-2019
2023-03-17 06:01:03 EST Source
 89. COVID19 Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
2023-03-17 03:58:25 EST Source
 90. COVID19 Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
2023-03-16 22:56:22 EST Source
 91. COVID19 Booster mRNA vaccination post-SARS-CoV-2 infection enhances functional qualities of T cell immunity
2023-03-16 17:06:45 EST Source
 92. COVID19 Breakthrough in COVID research: link between immune cells and long COVID
2023-03-16 13:59:55 EST Source
 93. COVID19 Post-truth epistemic beliefs rooted in the Dark Factor of Personality are associated with higher COVID-19 vaccination refusal
2023-03-16 09:36:13 EST Source
 94. COVID19 Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
2023-03-16 08:25:11 EST Source
 95. COVID19 Automated prediction of COVID-19 severity upon admission by chest X-ray images and clinical metadata aiming at accuracy and explainability
2023-03-16 07:04:58 EST Source
 96. COVID19 COVID-19 associated cognitive impairment: A systematic review
2023-03-16 05:54:30 EST Source

© Copyright hackingthevirus.com 2022-2023 Release Version 1.11162020

Return to top ►

© Copyright hackingai.app 2022-2023 Release Version 1.01202023
Return to top ►